Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cytoskeleton (Hoboken, N.J.)|November 26, 2019
Cytoskeletal makeup of the synapse: Shaft versus spineMichael Bucher, Tomas Fanutza, Marina Mikhaylova
Elife|November 10, 2015
APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapsesTomas Fanutza, Dolores Del Prete, Michael J Ford, et al.
Neurochemistry International|April 12, 2012
Reduced brain levels of DHEAS in hepatic coma patients: significance for increased GABAergic tone in hepatic encephalopathySamir Ahboucha, Giuseppe Talani, Tomas Fanutza, et al.
Acta Neuropathologica|July 16, 2020
miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's diseaseBen Readhead, Jean-Vianney Haure-Mirande, Diego Mastroeni, et al.
Eneuro|September 22, 2019
Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D1 Receptor SignalingMaria-Daniela Cirnaru, Chiara Melis, Tomas Fanutza, et al.
Cellular and Molecular Life Sciences : CMLS|August 9, 2024
Non-canonical function of ADAM10 in presynaptic plasticityJulia Bär, Tomas Fanutza, Christopher C Reimann, et al.
Plos Genetics|January 25, 2018
Mutations in THAP1/DYT6 reveal that diverse dystonia genes disrupt similar neuronal pathways and functionsZuchra Zakirova, Tomas Fanutza, Justine Bonet, et al.
Molecular Psychiatry|November 23, 2018
Correction: Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burdenJean-Vianney Haure-Mirande, Minghui Wang, Mickael Audrain, et al.
Acta Neuropathologica|June 15, 2017
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathologyJean-Vianney Haure-Mirande, Mickael Audrain, Tomas Fanutza, et al.
Molecular Psychiatry|October 5, 2018
Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burdenJean-Vianney Haure-Mirande, Minghui Wang, Mickael Audrain, et al.
Pageof 2